These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 19365387)

  • 1. [Efficacy and side-effects of the botulinum toxin A treatment in patients with focal dystonia].
    Likhachev SA; Rushkevich IuN; Chernukha TN; Veevnik EV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(3):27-31. PubMed ID: 19365387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of focal dystonia with botulinum toxin A].
    Sojer M; Wissel J; Müller J; Poewe W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():6-10. PubMed ID: 15506045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Botulinum toxin therapy for focal dystonia].
    Hahn K; Niklai E; Garzuly F; Szupera Z
    Orv Hetil; 2009 Jul; 150(29):1381-4. PubMed ID: 19581172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
    Ababneh OH; Cetinkaya A; Kulwin DR
    Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin physiology in focal hand and cranial dystonia.
    Karp BI
    Toxins (Basel); 2012 Nov; 4(11):1404-14. PubMed ID: 23202323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of botulinum toxin type A in treatment of different forms of focal dystonias in the Serbian population: experience of the Botulinum Toxin Outpatients Department.
    Tomić A; Vujović B; Svetel M; Misković ND; Petrović I; Pekmezović T; Kostić VS
    Vojnosanit Pregl; 2015 Dec; 72(12):1069-73. PubMed ID: 26898029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.
    Rosales RL; Ng AR; Santos MM; Fernandez HH
    Int J Neurosci; 2011; 121 Suppl 1():44-56. PubMed ID: 21348790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum Toxin Effects on Sensorimotor Integration in Focal Dystonias.
    De Bartolo MI; Manzo N; Ferrazzano G; Baione V; Belvisi D; Fabbrini G; Berardelli A; Conte A
    Toxins (Basel); 2020 Apr; 12(5):. PubMed ID: 32344856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Focal dystonias and their treatment with dysport (botulinum toxin type A)].
    Orlova OR; Timerbaeva SL; Khat'kova SE; Kotliarov VV; Korenko LA; Zalialova ZA; Fal'kovskiĭ IV; Shperling LP; Antipova LN; Antipenko EA; Mingazova LR; Soĭkher MI; Krasavina DA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(5):81-9. PubMed ID: 22951787
    [No Abstract]   [Full Text] [Related]  

  • 10. [Focal or Segmental Dystonia Resistant to Botulinum Toxin: How Do You Treat Patients in Whom Botulinum Toxin Treatment Has No Effect?].
    Nomura T
    Brain Nerve; 2022 May; 74(5):581-587. PubMed ID: 35589651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of botulinum A toxin (BOTOX) in different types of facial dystonia.
    Shoaib KK; Inam-ul-Haq ; Khan MD
    J Coll Physicians Surg Pak; 2009 Nov; 19(11):742-3. PubMed ID: 19889277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two different formulations of botulinum toxin A for the treatment of blepharospasm and hemifacial spasm.
    Wu CJ; Shen JH; Chen Y; Lian YJ
    Turk Neurosurg; 2011; 21(4):625-9. PubMed ID: 22194126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramuscular botulinum toxin A (BtxA) in complex regional pain syndrome.
    Kharkar S; Ambady P; Yedatore V; Schwartzman RJ
    Pain Physician; 2011; 14(3):311-6. PubMed ID: 21587336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment Effects of Botulinum Toxin Injection and Acupuncture on Blepharospasm Assessed by the Change in Lower Eyelid Tension.
    Bao FF; Li QS; Zhang ZY; Xiang MH
    Curr Eye Res; 2019 Jun; 44(6):679-683. PubMed ID: 30724635
    [No Abstract]   [Full Text] [Related]  

  • 15. High versus low concentration botulinum toxin A for benign essential blepharospasm: does dilution make a difference?
    Boyle MH; McGwin G; Flanagan CE; Vicinanzo MG; Long JA
    Ophthalmic Plast Reconstr Surg; 2009; 25(2):81-4. PubMed ID: 19300145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The occurrence of lateral shift in cervical dystonia.
    Esposito M; Peluso S; Dubbioso R; Allocca R; Iorillo F; Coppola A; Santoro L
    Neurol Sci; 2017 Apr; 38(4):683-686. PubMed ID: 28054172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dynamics of quality-of-life in patients with torticollis treated with botulinum toxin A].
    Likhachev SA; Gavrilenko LN; Chernukha TN; Rushkevich IuN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(4):30-5. PubMed ID: 19491807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of high-dose botulinum A toxin in benign essential blepharospasm: is too high too much?
    Pang AL; O'Day J
    Clin Exp Ophthalmol; 2006 Jul; 34(5):441-4. PubMed ID: 16872340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and risk factors of antibody-induced secondary failure of botulinum neurotoxin therapy.
    Walter U; Mühlenhoff C; Benecke R; Dressler D; Mix E; Alt J; Wittstock M; Dudesek A; Storch A; Kamm C
    Neurology; 2020 May; 94(20):e2109-e2120. PubMed ID: 32332130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphometric changes of sensorimotor structures in focal dystonia.
    Obermann M; Yaldizli O; De Greiff A; Lachenmayer ML; Buhl AR; Tumczak F; Gizewski ER; Diener HC; Maschke M
    Mov Disord; 2007 Jun; 22(8):1117-23. PubMed ID: 17443700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.